Another interesting finding that is consistent with these results and findings, even though statistical significance was not achieved, is that 3-ketosphinganine (Supplementary Table S1), which is one of the Cer precursors obtained by De Novo pathway, was also increased in control samples in comparison with both AA or CRC groups. This evidence concerns the gene CBLN1 and colorectal carcinoma.